The C-Terminal Fragment of Prostate-Specific Antigen, a 2331 Da Peptide, as a New Urinary Pathognomonic Biomarker Candidate for Diagnosing Prostate Cancer
Figure 5
Mass spectrum comparison of the PCa urinary samples before (a) and after (b) DRE.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Mass spectrum comparison of the PCa urinary samples before (a) and after (b) DRE.